REQUEST A DEMO
Total
USD $0.00
Search more companies

Podopharm Jakub Oleszek sp. k. (Poland)

Main Activities: Toilet Preparation Manufacturing
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Research and Development in the Social Sciences and Humanities
Full name: Podopharm Jakub Oleszek sp. k. Profile Updated: May 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Podopharm Jakub Oleszek sp. k. is based in Poland, with the head office in Kielce. The company operates in the Toilet Preparation Manufacturing sector. It was incorporated on October 10, 2019. From the latest financial highlights, Podopharm Jakub Oleszek sp. k. reported a net sales revenue increase of 41.49% in 2023. Its’ total assets recorded a growth of 118.04%. In, 2023, the company’s net profit margin increased by 3.67%.

Headquarters
Ul. Tektoniczna 6/22
Kielce; Swietokrzyskie; Postal Code: 25-640

Contact Details: Purchase the Podopharm Jakub Oleszek sp. k. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Podopharm Jakub Oleszek sp. k. report to view the information.
Incorporation Date:
October 10, 2019
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Ownership Details
Purchase this report to view the information.
86.96%
Purchase this report to view the information.
13.04%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Podopharm Jakub Oleszek sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
41.49%
Total operating revenue
42.32%
Operating profit (EBIT)
79.23%
Net Profit (Loss) for the Period
56.19%
Total assets
118.04%
Total equity
79.75%
Operating Profit Margin (ROS)
9.43%
Net Profit Margin
3.67%
Return on Equity (ROE)
-8.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?